Tag: omicron

Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older

-Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced early data from a Phase 2/3 clinical trial (NCT05472038)...

Pfizer busca autorización en EEUU para una vacuna modificada para ómicron

Pfizer Inc y su socio alemán BioNTech dijeron el lunes que solicitaron la autorización de Estados Unidos...

Want to stay up to date with the latest news?

We would love to hear from you! Please fill in your details and we will stay in touch. It's that simple!